Evidence map›Paper›PMID 33927201›Full record

ArticleNature communications2021

Etiological, epidemiological, and clinical features of acute diarrhea in China.

Li-Ping Wang, Shi-Xia Zhou, Xin Wang, Qing-Bin Lu, Lu-Sha Shi, Xiang Ren, Hai-Yang Zhang, Yi-Fei Wang, Sheng-Hong Lin, Cui-Hong Zhang and 28 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05226052 (Effect of the Use of Probiotic Saccharomyces Boulardii on Acute Viral Inflammatory Diarrhea Diagnosed With Multiplex PCR Technique, Randomized Clinical Trial), which is not on this map. Cited by 98 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 4 pooled it
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05226052 nacompletednot on this map

Effect of the Use of Probiotic Saccharomyces Boulardii on Acute Viral Inflammatory Diarrhea Diagnosed With Multiplex PCR Technique, Randomized Clinical Trial (RCT).

TypeinterventionalSponsorInstituto Mexicano del Seguro SocialRan2020 to 2022Enrolled46ConditionsViral DiarrheaArmsSaccharomyces boulardii (Floratil 600mg), 3 capsules of placebo
3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 4 syntheses or guidelines pooled it, 190 citations in OpenAlex.

  1. Efficacy and safety ofFrontiers in cellular and infection microbiology · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Frontiers in pediatrics · 2026
    Review
  18. Article
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 20 institutions in 4 countries.

Li-Ping Wang *Division of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
Shi-Xia Zhou *Anhui Medical University, Hefei, China.ORCID 0000-0001-5554-6068
Xin Wang *National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Qing-Bin LuDepartment of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing, China.ORCID 0000-0002-2804-0827
Lu-Sha ShiDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
Xiang RenDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
Hai-Yang ZhangState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Yi-Fei WangDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
Sheng-Hong LinDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
Cui-Hong ZhangDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
Meng-Jie GengDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
Xiao-Ai ZhangState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Jun LiSun Yat-sen University, Guangzhou, China.
Shi-Wen ZhaoYunnan Center for Disease Control and Prevention, Kunming, China.
Zhi-Gang YiShanghai Public Health Clinical Center, Shanghai, China.ORCID 0000-0002-4560-4970
Xiao ChenZhejiang University, Hangzhou, China.
Zuo-Sen YangLiaoning Provincial Center for Disease Control and Prevention, Shenyang, China.
Lei MengGansu Provincial Center for Disease Control and Prevention, Lanzhou, China.
Xin-Hua WangGansu Provincial Center for Disease Control and Prevention, Lanzhou, China.
Ying-Le LiuWuhan University, Wuhan, China.
Ai-Li CuiNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Sheng-Jie LaiWorldPop, School of Geography and Environmental Science, University of Southampton, Southampton, UK.
Meng-Yang LiuState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Yu-Liang ZhuDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
Wen-Bo XuNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Yu ChenZhejiang University, Hangzhou, China.
Jian-Guo WuWuhan University, Wuhan, China.ORCID 0000-0002-8326-2895
Zheng-Hong YuanFudan University, Shanghai, China.
Meng-Feng LiSun Yat-sen University, Guangzhou, China.ORCID 0000-0002-5103-6367
Liu-Yu HuangThe Institute for Disease Prevention and Control of PLA, Beijing, China.
Zhong-Jie LiDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China. lizj@chinacdc.cn.
Wei LiuState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China. liuwei@bmi.ac.cn.ORCID 0000-0002-9302-8170
Li-Qun FangAnhui Medical University, Hefei, China. fang_lq@163.com.ORCID 0000-0002-4981-1483
Huai-Qi JingNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Simon I HayDepartment of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0002-0611-7272
George F GaoChinese Centre for Disease Control and Prevention, Beijing, China.ORCID 0000-0002-3869-615X
Wei-Zhong YangChinese Centre for Disease Control and Prevention, Beijing, China.
Chinese Centers for Disease Control and Prevention (CDC) Etiology of Diarrhea Surveillance Study Team
Chinese Center For Disease Control and Prevention · CNSun Yat-sen University · CNInstitute of Microbiology · CNNational Institute for Communicable Disease Control and Prevention · CNWuhan University · CNGansu Provincial Center for Disease Control and Prevention · CNNational Institute for Viral Disease Control and Prevention · CNPeking University · CNShanghai Municipal Center For Disease Control Prevention · CNZhejiang University · CNShanghai Public Health Clinical Center · CNShenyang Center for Disease Control and Prevention · CNYunnan Center for Disease Control And Prevention · CNAnhui Medical University · CNFudan University · CNGansu Great Wall Electrical and Electronics Engineering Research Institute · CNGuangdong Provincial Center for Disease Control and Prevention · CNGuangzhou Center for Disease Control and Prevention · CNGuizhou Center for Disease Control and Prevention · CNHeilongjiang Center for Tuberculosis Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

National-based prospective surveillance of all-age patients with acute diarrhea was conducted in China between 2009‒2018. Here we report the etiological, epidemiological, and clinical features of the 152,792 eligible patients enrolled in this analysis. Rotavirus A and norovirus are the two leading viral pathogens detected in the patients, followed by adenovirus and astrovirus. Diarrheagenic Escherichia coli and nontyphoidal Salmonella are the two leading bacterial pathogens, followed by Shigella and Vibrio parahaemolyticus. Patients aged <5 years had higher overall positive rate of viral pathogens, while bacterial pathogens were more common in patients aged 18‒45 years. A joinpoint analysis revealed the age-specific positivity rate and how this varied for individual pathogens. Our findings fill crucial gaps of how the distributions of enteropathogens change across China in patients with diarrhea. This allows enhanced identification of the predominant diarrheal pathogen candidates for diagnosis in clinical practice and more targeted application of prevention and control measures.

Indexed as

AdolescentAdultAge FactorsCaliciviridae InfectionsChildChild, PreschoolChinaDiarrheaEscherichia coliEscherichia coli InfectionsGastroenteritisHumansMiddle AgedNorovirusRotavirusRotavirus Infections

Identifiers

PMID33927201
PMCPMC8085116
OpenAlexW3159506811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.